Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cardiol Therapeutics (CRDL)
NASDAQ:CRDL
RESEARCH TOOLSreports
Cardiol Therapeutics (CRDL) Stock Price & Analysis
251 Followers
CRDL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.66 - $3.12
Previous Close$2.25
Volume253.12K
Average Volume (3M)514.00K
Market Cap
$156.16M
Enterprise Value$130.92M
Total Cash (Recent Filing)C$34.93M
Total Debt (Recent Filing)C$174.34K
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Aug 13, 2024EPS Estimate
-$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.34
Shares Outstanding68,998,313
10 Day Avg. Volume1,159,324
30 Day Avg. Volume514,003
Standard Deviation0.22
R-Squared0.06
Alpha0.00700
Financial Highlights & Ratios
Price to Book (P/B)6.18
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$9.25Price Target Upside311.11% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Cardiol Therapeutics News
PremiumCompany Announcements
Cardiol Therapeutics Gains Key Legal Consent
PremiumCompany Announcements
Cardiol Therapeutics Shareholders Approve Resolutions
PremiumCompany Announcements
Cardiol Therapeutics Advances Heart Disease Treatments
PremiumCompany Announcements
Cardiol Therapeutics’ Promising Pericarditis TreatmentOwnership Overview
6.55% Insiders
0.08% Mutual Funds
2.78% Other Institutional Investors
90.60% Public Companies and
Individual Investors
CRDL FAQ
What was Cardiol Therapeutics’s price range in the past 12 months?
Cardiol Therapeutics lowest stock price was $0.66 and its highest was $3.12 in the past 12 months.
What is Cardiol Therapeutics’s market cap?
Currently, no data Available
When is Cardiol Therapeutics’s upcoming earnings report date?
Cardiol Therapeutics’s upcoming earnings report date is Aug 13, 2024 which is in 16 days.
How were Cardiol Therapeutics’s earnings last quarter?
Cardiol Therapeutics released its earnings results on May 14, 2024. The company reported -$0.087 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.087.
Is Cardiol Therapeutics overvalued?
According to Wall Street analysts Cardiol Therapeutics’s price is currently Undervalued.
Does Cardiol Therapeutics pay dividends?
Cardiol Therapeutics does not currently pay dividends.
What is Cardiol Therapeutics’s EPS estimate?
Cardiol Therapeutics’s EPS estimate is -$0.1.
How many shares outstanding does Cardiol Therapeutics have?
Cardiol Therapeutics has 68,998,314 shares outstanding.
What happened to Cardiol Therapeutics’s price movement after its last earnings report?
Cardiol Therapeutics reported an EPS of -$0.087 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.422%.
Which hedge fund is a major shareholder of Cardiol Therapeutics?
Currently, no hedge funds are holding shares in CRDL
---
Cardiol Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.25 (311.11% Upside)
$9.25 (311.11% Upside)
Insider Transactions
Bought Shares
Worth $133.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
116.34%
12-Months-Change
Fundamentals
Return on Equity
-92.40%
Trailing 12-Months
Asset Growth
-40.92%
Trailing 12-Months
Company Description
Cardiol Therapeutics
Cardiol Therapeutics, Inc. is a biotechnology company, which engages in the research and commercial development of pharmaceutical cannabidiol products and targeted therapies for inflammatory diseases. Its products pipelines include heart failure products, glioblastoma multiforme and pharmaceutical cannabidol. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada.
---
CRDL Stock 12 Month Forecast
Average Price Target
$9.25
▲(311.11% Upside)
Technical Analysis
Best Analysts Covering CRDL
1 Year
1 Year Success Rate
7/9 ratings generated profit
1 Year Average Return
+47.83%
reiterated a buy rating last month
Copying Edward Nash's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +47.83% per trade.
---